Share

August 2017; 7 (4) Research

Virtual visits for Parkinson disease

A multicenter noncontrolled cohort

Ryan E. Korn, Aparna Wagle Shukla, Maya Katz, H. Tait Keenan, Steven Goldenthal, Peggy Auinger, William Zhu, Michael Dodge, Kyle Rizer, Meredith A. Achey, Erica Byrd, Richard Barbano, Irene Richard, Kelly L. Andrzejewski, Heidi B. Schwarz, E. Ray Dorsey, Kevin M. Biglan, Gail Kang, Sulada Kanchana, Ramon Rodriguez, Caroline M. Tanner, Nicholas B. Galifianakis
First published June 13, 2017, DOI: https://doi.org/10.1212/CPJ.0000000000000371
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
118

Share

Article Information

vol. 7 no. 4 283-295
DOI: 
https://doi.org/10.1212/CPJ.0000000000000371
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
2163-0402
Online ISSN: 
2163-0933
History: 
  • Received December 29, 2016
  • Accepted March 31, 2017
  • First Published June 13, 2017.

Article Versions

Copyright & Usage: 
© 2017 American Academy of Neurology

Author Disclosures

    1. Ryan E. Korn, BA,
    2. Aparna Wagle Shukla, MD,
    3. Maya Katz, MD,
    4. H. Tait Keenan, BA,
    5. Steven Goldenthal, BS,
    6. Peggy Auinger, MS,
    7. William Zhu, BA,
    8. Michael Dodge, BA,
    9. Kyle Rizer, BA,
    10. Meredith A. Achey, BM,
    11. Erica Byrd, MD,
    12. Richard Barbano, MD, PhD,
    13. Irene Richard, MD,
    14. Kelly L. Andrzejewski, DO, PhD,
    15. Heidi B. Schwarz, MD,
    16. E. Ray Dorsey, MD, MBA,
    17. Kevin M. Biglan, MD, MPH,
    18. Gail Kang, MD,
    19. Sulada Kanchana, MD,
    20. Ramon Rodriguez, MD,
    21. Caroline M. Tanner, MD, PhD and
    22. Nicholas B. Galifianakis, MD
  1. Ryan E. Korn, BA,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Aparna Wagle Shukla, MD,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NIH, National Organization for Rare Disorders

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. Dystonia Coalition, Dystonia Medical Research Foundation, Blepharospasm Research Foundation

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Maya Katz, MD,
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. 1) ExpertConnect 2) Schlessinger Associates 3) Guidepoint 4) Putnam Associates 5) GLG Consulting 6) Medscape 7) Bagatto 8) Cowen and Company

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. 1) NIH NINR, 1R01NR016037-01A1, Co-Investigator, 2017-2021

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. 1) Patient Centered Outcomes Research Institute 2) Davis Phinney Foundation 3) National Parkinson Foundation

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. H. Tait Keenan, BA,
    5. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. Steven Goldenthal, BS,
    6. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  6. Peggy Auinger, MS,
    7. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  7. William Zhu, BA,
    8. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  8. Michael Dodge, BA,
    9. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  9. Kyle Rizer, BA,
    10. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  10. Meredith A. Achey, BM,
    11. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. (1) HD Insights, Deputy Editor, 2013-2017

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  11. Erica Byrd, MD,
    12. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  12. Richard Barbano, MD, PhD,
    13. Scientific Advisory Boards:

    1. Allergan

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. Neurotoxin Association, non-commercial entity: I received travel expenses for workshop presentation. Jagellonian University, Poland: academic institution: I received travel honoraria for lectures/participation in conference

    Editorial Boards:

    1. Neurology Clinical Practice, Associate editor, 2011- present

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other activities:

    1. I receive stock equity from Visual Dx as Neurology Section Editor

    Clinical procedures or imaging studies:

    1. University of Rochester, botulinum toxin injections, 30% effort, since 1994

    Research Support, Commercial Entities:

    1. 1. Vaccinex 2. Biotie 3. Allergan

    Research Support, Government Entities:

    1. NIH, NINDS, ORDR: Dystonia Coalition Projects, Site PI Stock/Stock Options, Medical Equipment & Materials: VisualDx, 2014-present

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. Expert witness in legal proceedings including malpractice, but NOT involving commercial entities

  13. Irene Richard, MD,
    14. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. (NIH/NINDS) STEADY-PD III clinical trial of isradipine vs. placebo in Parkinson's disease, site investigator, 2015-2019 PCORI

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. Michael J Fox Foundation, site investigator for (1)study of buspirone for anxiety in PD 2016-2019 and (2) Parkinson's Progression Marker Initiative (PPMI) 2011- present (ongoing follow-up after 5 year initial study)

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  14. Kelly L. Andrzejewski, DO, PhD,
    15. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. Dystonia Medical Research Foundation

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  15. Heidi B. Schwarz, MD,
    16. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. Travel Expenses for serving on board of directors and chair of practice committee for AAN, honoraria from AAN for presentations at the annual meeting 2014 to present

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. PCORI, NCT0203859 investigator, 2015-2016

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. Davis Phinney Foundation : NCT02144220 Michael J. Fox Foundation

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. Expert witness for plaintiff

  16. E. Ray Dorsey, MD, MBA,
    17. Scientific Advisory Boards:

    1. Shire Pharmaceuticals, Huntington's Disease Society of America

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. received travel funding and/or honoraria from the American Academy of Neurology, American Neurological Association

    Editorial Boards:

    1. Editorial board member for the Journal of Huntington's Disease; Editor of HD Insights; Editor of Digital Biomarkers

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. 23andMe,Abbott Nutrition,Abbvie,Amgen,Biogen,Clintrex, GlaxoSmithKline,Grand Rounds,LundbeckMC10, MedAvante, Medico Legal services,NIH/NINDSOptio, Shire, Teva,UCB, Voyager Therapeutics,State of Georgia,Mednick Asssociates,Putnam Associates

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. Clinical practice, including telemedicine, as a movement disorder neurologist (20%)

    Research Support, Commercial Entities:

    1. Abbvie,AMC Health, Avid Radiopharmaceuticals, BioMarin,GlaxoSmithKline,Great Lakes Neurotechnologies, Lundbeck, Medtronic, Prana Biotechnology,Raptor Pharmaceuticals, Roche, Teva Pharmaceuticals

    Research Support, Government Entities:

    1. National Institute of Neurological Disorders and Stroke, Patient-Centered Outcomes Research Institute

    Research Support, Academic Entities:

    1. University of California Irvine,Duke University

    Research Support, Foundations and Societies:

    1. Burroughs Wellcome Fund,Davis Phinney Foundation, Michael J. Fox Foundation, Safra Foundation,Greater Rochester Health Foundation, Huntington Study Group,National Science Foundation

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. Grand Rounds (stock options)BlackFynn (stock options)

    Legal Proceedings:

    1. has received compensation for expert testimony

  17. Kevin M. Biglan, MD, MPH,
    18. Scientific Advisory Boards:

    1. Psyadon Pharmaceuticals Inc. Data and Safety Monitoring Board (DSMB)Member vin Ecopipam Treatment of Tourette?s Syndrome in Subjects 7-17 Years TEVA Pharmaceuticals Advisory Board Member

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Editorial Board, Journal of Huntington disease, 2011-

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. I am currently employed by Eli Lilly

    Consultancies:

    1. KJT Consulting, Teva, International Center of Postgraduate Medical Education, North American Center for Continuing Medical Education, and WebMD Global

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Presbyterian Home of Central New York, Susquehanna Nursing and Rehabilitation Center, Samaritan Keep Home, Sitrin NeuroCare and Focus Otsego, AMC Health Lundbeck

    Research Support, Government Entities:

    1. 1.)NINDS 5U01NS080840 PI, 04/1/14 -3/31/19 2.)NINDS P20, Project 2 lead, 3/1/15-2/28/17 3.)PCORI, Steering Committee, 9/1/13-8/31/16

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. (1) National Parkinson Foundation (2) Michael J. Fox Foundation (3) Huntington Disease Society of America (4) Greater Rochester Health Foundation

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. Eli Lilly, 2017

    Legal Proceedings:

    1. NONE

  18. Gail Kang, MD,
    19. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  19. Sulada Kanchana, MD,
    20. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  20. Ramon Rodriguez, MD,
    21. Scientific Advisory Boards:

    1. Acadia Pharmaceuticals, Abbvie, Teva.

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. Abbvie-Honoraria, Allergan-Honoraria.

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Abbvie, Acadia, Cynapsus Therapeutics

    Speakers' Bureaus:

    1. Abbvie, Acadia, Allergan.

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Abbvie, Auspex, Biotie.

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  21. Caroline M. Tanner, MD, PhD and
    22. Scientific Advisory Boards:

    1. (1) Michael J Fox Foundation, (2) Voyager Therapeutics, (3) Biotie Therapies, Inc. (4) NINDS, NIH (5) Department of Defense (6) Parkinson Disease Foundation (7) Partners in Health (8) NIEHS, NIH (9) IntecPharma

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. (1) International Parkinson's Disease and Movement Disorders Society, faculty stipend; (2) Cure Parkinson's Trust, travel to attend review meeting; (3) Korean Movement Disorders Society, faculty stipend

    Editorial Boards:

    1. (1) Journal of Parkinson's Disease, editorial advisory board member, 2011 - present, (2) Annals of Neurology, editorial advisory board, 2014 - present, (3) npj Parkinson's Disease, editorial advisory board, 2015 - present, (4) Journal of Neurology, 2016 - present

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. (1) Neurocrine Biosciences (2) Adamas Pharmaceuticals (3) Ultragenyx Pharmaceuticals (4) Cynapsus Therapeutics (5) Sage Bionetworks

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. (1) Department of Defense W81XWH-13-1-0054 , Role: PI, 4/1/2013 ? 3/31/2018 (2) NIEHS, NIH, R01 ES017462, Role: Co-investigator, 9/1/2009- 8/31/2016 (3) NIEHS, NIH, R01ES020718, Role: Subproject PI, 8/5/2014- 5/31/2017 (4) R21 NIOSH, Role: Co-investigator, 9/1/2013-8/31/2016

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. (1). Michael J Fox Foundation, (2). Parkinson's Disease Foundation

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  22. Nicholas B. Galifianakis, MD
    23. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. (1) Dorskind Family Foundation, a philanthropic gift of funding

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. (1) Boston Scientific Corporation.

    Research Support, Government Entities:

    1. (1) National Institutes of Health.

    Research Support, Academic Entities:

    1. (1) Patient-Centered Outcomes Research Institute (PCORI).

    Research Support, Foundations and Societies:

    1. (1) Davis Phinney Foundation.

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. University of Rochester School of Medicine and Dentistry (REK, HTK); Center for Human Experimental Therapeutics (REK, HTK, SG, PA, WZ, MAA, ERD, KMB) and Department of Neurology (PA, RB, IR, KLA, HBS, ERD, KMB, SK), University of Rochester, NY; Center for Movement Disorders and Neurorestoration (AWS, KR), Department of Neurology, University of Florida, Gainesville; Department of Neurology (MK, MD, EB, CMT, NBG), University of California–San Francisco; Parkinson's Disease Research, Education and Clinical Center (MK, MD, EB, CMT, NBG), San Francisco Veterans Affairs Medical Center, CA; University of Michigan Medical School (WZ), Ann Arbor; Department of Neurology (KLA), University at Buffalo, NY; Neurology Private Practice (GK), Berkeley, CA; and Department of Internal Medicine (RR), University of Central Florida College of Medicine, Orlando, FL.
  1. Correspondence to:
    ray.dorsey{at}chet.rochester.edu
View Full Text

Article usage

Article usage: June 2017 to April 2022

AbstractFullPdfSource
Jun 201711505Highwire
Jul 201744104Highwire
Aug 20178092629Highwire
Sep 2017469423Highwire
Oct 201723826Highwire
Nov 201712214Highwire
Dec 20173543Highwire
Jan 201855147Highwire
Feb 20182921Highwire
Mar 20183945Highwire
Apr 20183351Highwire
May 20182421Highwire
Jun 20183100Highwire
Jul 20183651Highwire
Aug 20182301Highwire
Aug 2018189pmc
Sep 20181511Highwire
Oct 20182300Highwire
Nov 20182301Highwire
Dec 20185900Highwire
Jan 20194201Highwire
Feb 20192810Highwire
Mar 20192411Highwire
Apr 20192600Highwire
May 20191800Highwire
Jun 20191300Highwire
Jul 2019900Highwire
Aug 20191823Highwire
Sep 20191900Highwire
Oct 20193112Highwire
Nov 20191910Highwire
Dec 20193500Highwire
Jan 20204210Highwire
Feb 20202810Highwire
Mar 20202100Highwire
Apr 20202810Highwire
May 20202940Highwire
Jun 20203500Highwire
Jul 20202300Highwire
Aug 20203500Highwire
Sep 20203033Highwire
Oct 20203200Highwire
Nov 20202111Highwire
Dec 20203200Highwire
Jan 20215100Highwire
Feb 20211700Highwire
Mar 20212200Highwire
Apr 20214000Highwire
May 20212210Highwire
Jun 20212601Highwire
Jul 20211900Highwire
Aug 20213801Highwire
Sep 20214501Highwire
Oct 20212700Highwire
Nov 20211711Highwire
Dec 20211700Highwire
Jan 20225100Highwire
Feb 20222611Highwire
Mar 20221600Highwire
Apr 20223510Highwire

Cited By...

The Nerve!: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Topics Discussed

Alert Me